• We specialize in small molecule inhibitors, agonists, antagonists and screening libraries!
Search Site
Related Products
BMS-911543JAK2 inhibitor,selective small molecule


Catalog No. A4152
Size Price Stock Qty
5mg $168.00 Ship Within 10-14 Days
10mg $302.00 Ship Within 10-14 Days
25mg $470.00 Ship Within 10-14 Days
50mg $670.00 Ship Within 10-14 Days

Tel: +1-832-696-8203

Email: sales@apexbt.com

Worldwide Distributors

Sample solution is provided at 25 µL, 10mM.

Quality Control

Quality Control & MSDS

View current batch:

Chemical structure


Biological Activity

Description BMS-911543 is a selective small-molecule inhibitor of Janus tyrosine kinase 2 (JAK2) with IC50 value of 1 nM.
Targets JAK2          
IC50 1 nM          

BMS-911543 Dilution Calculator

Concentration (start)
Volume (start)
Concentration (final)
Volume (final)


BMS-911543 Molarity Calculator



Chemical Properties

Cas No. 1271022-90-2 SDF Download SDF
Canonical SMILES CCN1C(=CC2=C3C(=C(N=C21)NC4=NN(C(=C4)C)C)N=CN3C)C(=O)N(C5CC5)C6CC6
Formula C23H28N8O M.Wt 432.52
Solubility DMSO mg/mL Water mg/mL Ethanol mg/mL Storage Store at -20°C
General tips N/A
Shipping Condition N/A


BMS-911543 is a selective small-molecule inhibitor of JAK2 with IC50 value of 1.1nM [1].

BMS-911543 is a reversible pyrrolopyridine ATP-competitive JAK2 inhibitor with a high selectivity. In the in vitro assay using human recombinant JAK enzyme, BMS-911543 displays an IC50 value of 1.1nM against JAK2 and the Ki value is 0.48nM. The inhibition activity and affinity against JAK2 are both much higher than those against JAK1 and JAK3. Besides that, BMS-911543 also has efficacy against other kinases, such as Lyn and the c-FMS receptor tyrosine kinase. In JAK-dependent cells such as SET2 or Ba/F3, the treatment of BMS-911543 causes an anti-proliferative effect with IC50 values of 60 and 70nM, respectively. The cell lines depending on other JAK family members do not show significant anti-proliferative response to BMS-911543. The colony growth assays prove that BMS-911543 can suppress the growth of MPN patient-derived cells and is more potent in the JAK2V617F pathway compared with the JAK2WT pathway. BMS-911543 is also found to be potent in vivo in both the JAK2WT pathway and the JAK2V617F pathway through suppressing pSTAT5 induction [1].

[1] Purandare AV, McDevitt TM, Wan H, You D, Penhallow B, Han X, Vuppugalla R, Zhang Y, Ruepp SU, Trainor GL, Lombardo L, Pedicord D, Gottardis MM, Ross-Macdonald P, de Silva H, Hosbach J, Emanuel SL, Blat Y, Fitzpatrick E, Taylor TL, McIntyre KW, Michaud E, Mulligan C, Lee FY, Woolfson A, Lasho TL, Pardanani A, Tefferi A, Lorenzi MV. Characterization of BMS-911543, a functionally selective small-molecule inhibitor of JAK2. Leukemia. 2012 Feb;26(2):280-8.